# HME Square Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hme-square-co

- Industry: Medical Devices & Equipment
- Headquarters: Daejeon, South Korea
- Website: www.hmesquare.com/
- Total disclosed funding: $0.6M
- Latest round: Seed (Jun 1, 2021)
- Investors on record: 2

## About

Founded in 2020 and based in Daejeon, South Korea, HME Square Co., Ltd. operates as a developer of medical device that monitor blood sugar and help manage diabetes. The company was founded by its CEO, Yoonho Khang. In December 2023, HME Square Co., Ltd. raised KRW 4 billion in pre-series A funding from LB Investmen.

The company offers its primary product, Glucosound, which is a detachable wearable that serves as a non-invasive continuous glucose meter, eliminating the need for blood sampling or the discomfort of needles. This device operates on the principle of photoacoustics, utilizing light and sound to provide accurate, convenient, and painless blood glucose monitoring. In addition, HME Square also provides a mobile application that allows blood sugar data to be directly shared and monitored by family members or healthcare professionals, ensuring timely interventions and safety measures.

The organization plans to use the December 2023 funding to upgrade its products and technology, as well as recruit personnel.

## Funding rounds

- Seed, Jun 1, 2021, $0.5M — Korea Tech Incubator for Startup, POSTECH Holdings
- Seed, Apr 30, 2021, $0.2M — POSTECH Holdings

## Investors

- POSTECH Holdings (https://capitalatlas.ai/funds/postech-holdings) — Seed
- Korea Tech Incubator for Startup — Seed